Traditional Chinese medicine
BupleurumBupleurum chinense
Bupleurum (chai hu) leads Xiao Yao San (6 dyspepsia trials, RR 1.15 vs drugs); the Kampo formula sho-saiko-to was behind 26% of 73 reported herbal pneumonitis cases.
- Botanical name
- Bupleurum chinense
- Part used
- root, dried; often vinegar-fried
- Also called
- pinyin Chai hu (柴胡); Chinese thoroughwax, Hare’s ear root, Bupleuri radix, Saiko (Japanese)
- Used in
- Traditional Chinese medicine
- Taken for
- Stress and the gut, Cramping and pain, Bloating, Liver and bile
- Sold as
- decoction, pill, granule extract, patent medicine, dried slices
What is meant by bupleurum
Bupleurum, or chai hu, is the dried root of Bupleurum chinense and the related B. scorzonerifolium, plants of the carrot family. A review in BioMed Research International says the root has been used for more than 2,000 years in China, Japan, Korea and other Asian countries, and that it contains triterpenoid saponins (the saikosaponins), essential oils, polyacetylenes, flavonoids and lignans. Chai hu is also often cut and fried with vinegar (cu chai hu), a preparation the tradition uses to direct the herb toward the liver.
In the digestive formulas it is the lead of Xiao Yao San (sold as the pill Xiao Yao Wan) and of Chai Hu Shu Gan San, and it is in Xiao Chai Hu Tang, the formula that Kampo calls sho-saiko-to. The first two share an idea: the tradition holds that the gut cramps and bloats when emotional strain makes liver qi stagnate. The root is taken as a decoction, a pill, a granule extract, and in patent medicines, almost always with other herbs.
In the traditions
Traditional Chinese medicine (about TCM)
Chai hu is given in the materia medica as bitter, acrid and slightly cold, entering the liver and gallbladder channels, with the actions of releasing the exterior, clearing heat at the shaoyang level, spreading liver qi and raising yang qi. For the gut the tradition uses it where it sees liver qi stagnating and pressing on the spleen: flank and abdominal distention, cramping, irritability, alternating constipation and loose stools, and a sense of a lump in the throat. Xiao Yao San pairs it with dang gui, white peony, white atractylodes, poria, licorice, ginger and mint for what the texts call liver constraint with spleen deficiency. Liver qi stagnation is the tradition’s pattern name and not a diagnosis in Western terms.
What the plant contains
The saikosaponins (a, b2, c, d) are the compounds most studied. A review in BioMed Research International reports anti-inflammatory, antipyretic, antiviral, hepatoprotective and immunomodulatory effects in cell and animal studies, and the same review reports that the root can cause hepatotoxicity, particularly in high doses and with long-term use. Pharmacokinetic work in rats showed that the major saikosaponins were absorbed rapidly after an oral extract. These are laboratory and animal findings, and we found no human trial that tested a single bupleurum compound for a gut outcome.
What has been tested in people
We could not find a controlled trial of bupleurum root alone for a gut outcome. The human data are formulas that contain it, and the studies are open to bias.
The most direct are the Xiao Yao San trials for functional dyspepsia. A meta-analysis of 6 trials with 707 people found a higher total clinical efficacy rate than Western medicine (RR 1.15, 95% CI 1.05 to 1.26; heterogeneity high), a greater reduction of dyspepsia symptom scores (SMD -0.72) and fewer adverse events (RR 0.20). An earlier analysis of 14 trials found an odds ratio of 3.26 against prokinetic drugs, and the authors said publication bias and flawed methods may have amplified it. A network meta-analysis of placebo-controlled trials ranked Xiao Yao Pill as probably having a large benefit on global dyspepsia symptoms (risk difference 0.37, 0.03 to 0.99). For modified Chai Hu Shu Gan San, 22 trials with 1,998 people gave RR 1.20 (1.14 to 1.27) against prokinetics, and every included trial was at high risk of bias.
Most of these pooled analyses compare the formula with active drugs; the network analysis is the one built only on placebo-controlled trials, and its confidence interval is wide (0.03 to 0.99).
Not tested: bupleurum root alone for any digestive symptom, and Xiao Yao San in a large placebo-controlled IBS trial, which we could not find.
| Study | Dose | What it found |
|---|---|---|
| Meta-analysis of 6 RCTs, 707 people with functional dyspepsia (Xiao Yao San vs Western medicine) PMID 37124216 | Formula; doses varied | Total efficacy RR 1.15 (1.05 to 1.26); dyspepsia score SMD -0.72; adverse events RR 0.20 |
| Meta-analysis of 14 RCTs, functional dyspepsia (modified Xiao Yao San vs prokinetic drugs) PMID 19702899 | Modified formula; doses varied | Symptoms OR 3.26 (2.24 to 4.47); authors flag publication bias and methodological flaws |
| Network meta-analysis of 15 placebo-controlled RCTs, 12 formulas, functional dyspepsia PMID 34592339 | Formulas; doses varied | Xiao Yao Pill: global symptoms risk difference 0.37 (0.03 to 0.99) |
| Meta-analysis of 22 RCTs, 1,998 people with functional dyspepsia (modified Chai Hu Shu Gan San vs prokinetics) PMID 23762161 | Modified formula; doses varied | RR 1.20 (1.14 to 1.27); all trials at high risk of bias |
| Case series review, 73 patients with Japanese herbal medicine-induced pneumonitis PMID 28274529 | Not applicable | Sho-saiko-to was the cause in 26%; 3 patients (4%) died; 36% recovered by stopping the medicine |
Doses used in trials and traditional preparations
None of the abstracts we read gives a bupleurum dose that can be separated from the rest of the formula. The traditional preparation is a water decoction of the sliced root, raw or vinegar-fried, simmered with the other herbs and drunk in divided doses. Xiao Yao San is also sold as pills and granules, and sho-saiko-to is sold as a standardized extract in Japan. The hepatotoxicity noted in a review of the root occurred at high doses with long-term use.
Treat these figures as a record of what was studied. Whether any amount of bupleurum suits a particular person is a question for a clinician or pharmacist who knows their history.
Safety
The notable finding is pneumonitis with Kampo formulas. A review of 73 cases of Japanese herbal medicine-induced pneumonitis found sho-saiko-to responsible in 26 percent; 36 percent recovered after stopping the medicine, 18 percent needed mechanical ventilation and 4 percent (three patients) died. Those formulas also contain scutellaria and licorice, and a Chinese review concluded that several factors were involved, including use with interferon. Liver injury at high doses over long periods is noted in a review of the root. Separately, aristolochic acid is not a constituent of bupleurum, but bupleurum is an ingredient of Long Dan Xie Gan Tang, which also calls for mu tong, a name that has been applied to Aristolochia manshuriensis; European regulators recorded renal failure from that substitution, including 17 Chinese cases, 12 of them fatal.
Drug interactions
The pneumonitis cases are the interaction signal that matters: the Chinese review of the sho-saiko-to episode points to combined use with interferon as one contributing factor, and a Japanese case review links several formulas that contain scutellaria and licorice. No controlled interaction study of bupleurum root with a medicine turned up. Xiao Yao San and its relatives also contain licorice, whose potassium and blood-pressure effects apply to the finished formula.
Which product, for your symptoms?
Answer a few questions about your symptoms, routine and medicines, and the quiz names one product, with the reasons it won.
Take the quizRelated herbs
The questions that come up
What is Xiao Yao San?
It is a classical formula led by bupleurum, with dang gui, white peony, white atractylodes, poria, licorice, ginger and mint. In the texts it is for liver qi stagnation pressing on a weak spleen, which includes cramping, bloating and mood-related digestive trouble.
Does bupleurum help with dyspepsia?
A meta-analysis of 6 trials in 707 people found the Xiao Yao San formula better than Western medicine on efficacy (RR 1.15). The comparison was not against placebo, and the authors rated the evidence from very low to high by outcome.
Why is bupleurum linked to lung problems?
The Kampo formula sho-saiko-to was behind 26 percent of 73 reported cases of herbal pneumonitis in Japan. The formulas involved also contain scutellaria and licorice, and a Chinese review says several factors, including interferon use, were involved.
Can bupleurum harm the liver?
A review of the root notes hepatotoxicity at high doses with long-term use. The Chinese review found no reports of interstitial pneumonitis or drug-induced liver injury from bupleurum formulas in Chinese literature.
Is chai hu the same as the bupleurum in supplements?
Supplements are often extracts and may name a different species from the Pharmacopoeia roots. The traditional use is the sliced root in a decoction with other herbs.
Sources
- Ha NY et al., "Safety and efficacy of Xiaoyao-san for the treatment of functional dyspepsia: a systematic review and meta-analysis of randomized controlled trials", Front Pharmacol 2023;14:1114222 pubmed.ncbi.nlm.nih.gov/37124216
- Qin F, Huang X, Ren P, "Chinese herbal medicine modified xiaoyao san for functional dyspepsia: meta-analysis of randomized controlled trials", J Gastroenterol Hepatol 2009;24:1320-5 pubmed.ncbi.nlm.nih.gov/19702899
- Ho L et al., "Herbal medicine for functional dyspepsia: Network meta-analysis of placebo-controlled randomised trials", J Ethnopharmacol 2022;283:114665 pubmed.ncbi.nlm.nih.gov/34592339
- Yang N et al., "Modified chaihu shugan powder for functional dyspepsia: meta-analysis for randomized controlled trial", Evid Based Complement Alternat Med 2013;2013:791724 pubmed.ncbi.nlm.nih.gov/23762161
- Enomoto Y et al., "Japanese herbal medicine-induced pneumonitis: A review of 73 patients", Respir Investig 2017;55:138-44 pubmed.ncbi.nlm.nih.gov/28274529
- Wu SX et al., "Re-evaluation upon suspected event approach for post-marketing clinical study: lessons from adverse drug events related to Bupleuri Radix preparations", Zhongguo Zhong Yao Za Zhi 2014;39:2983-8 pubmed.ncbi.nlm.nih.gov/25423845
- Yang F et al., "Radix Bupleuri: A Review of Traditional Uses, Botany, Phytochemistry, Pharmacology, and Toxicology", Biomed Res Int 2017;2017:7597596 pubmed.ncbi.nlm.nih.gov/28593176
- European Agency for the Evaluation of Medicinal Products, Working Party on Herbal Medicinal Products, Position paper on the risks associated with the use of herbal products containing Aristolochia species (EMEA/HMPWP/23/00) www.ema.europa.eu/en/documents/position/position-paper-risks-associated-use-herbal-products-containing-aristolochia-species_en.pdf
- Bensky D, Clavey S, Stoger E, Chinese Herbal Medicine: Materia Medica, 3rd ed., Eastland Press, 2004 (nature, flavor, channels and actions as the tradition gives them) www.eastlandpress.com/products/chinese-herbal-medicine-materia-medica-portable-3rd-ed
- Bensky D, Barolet R, Ellis A, Scheid V, Chinese Herbal Medicine: Formulas and Strategies, 2nd ed., Eastland Press, 2009 (formula compositions) www.eastlandpress.com/products/chinese-herbal-medicine-formulas-strategies-portable-2nd-edition